Webinar Sponsored by
Decentralised trials are no longer a thing of the future. This session will focus on how COVID-19 pandemic presented an opportunity to re-envision clinical trials, a change that was long overdue. Aparajeeta will present a snapshot of approaches to trial conduct, the perceived legal, regulatory, and practical challenges with DCT design behind implementing decentralized trials, and the practical implementations – while remaining focused on trial quality and efficiency.
Senior Solutions Consultant (APeJ)
Aparajeeta Priyadarasini has over 14 years of experience in the healthcare and life sciences industry. She has held various roles in global pharmaceutical companies and contract research organization, covering clinical research, biotechnology, medical devices. She was responsible for clinical operation of different study phases for Sanofi Aventis, Asia-Pacific Regional HQ prior to Medidata. In her current role, Aparajeeta provides consulting to the pharmaceutical, biotech and CRO companies on clinical operations processes and technologies.